Hohmann, N., Bozorgmehr, F., Christopoulos, P., Mikus, G., Blank, A., Burhenne, J., . . . Haefeli, W. E. (2021). Pharmacoenhancement of low crizotinib plasma concentrations in patients with anaplastic lymphoma kinase-positive non-small cell lung cancer using the CYP3A inhibitor cobicistat. Clinical and translational science, 14(2), . https://doi.org/10.1111/cts.12921
Chicago-Zitierstil (17. Ausg.)Hohmann, Nicolas, Farastuk Bozorgmehr, Petros Christopoulos, Gerd Mikus, Antje Blank, Jürgen Burhenne, Michael Thomas, und Walter E. Haefeli. "Pharmacoenhancement of Low Crizotinib Plasma Concentrations in Patients with Anaplastic Lymphoma Kinase-positive Non-small Cell Lung Cancer Using the CYP3A Inhibitor Cobicistat." Clinical and Translational Science 14, no. 2 (2021). https://doi.org/10.1111/cts.12921.
MLA-Zitierstil (9. Ausg.)Hohmann, Nicolas, et al. "Pharmacoenhancement of Low Crizotinib Plasma Concentrations in Patients with Anaplastic Lymphoma Kinase-positive Non-small Cell Lung Cancer Using the CYP3A Inhibitor Cobicistat." Clinical and Translational Science, vol. 14, no. 2, 2021, https://doi.org/10.1111/cts.12921.